Arbutus Biopharma ABUS
NASDAQ ABUS
$3.83 +0.11 (+2.82%)
As of: Nov 10, 2026 · 3:59 PM EST

Arbutus Biopharma (ABUS) Goodwill impairment charges (2019)

Updated

Arbutus Biopharma's Goodwill impairment charges came in at $29,000 for Q4 2019, down 99.9% from the prior quarter.

Analysis

Arbutus Biopharma (ABUS) Goodwill impairment charges (2019) Analysis & Trends

For FY2019, Arbutus Biopharma's Goodwill impairment charges was $22.5 million.

  • Goodwill impairment charges carries a three-year compound annual growth rate of -45.4% (FY2016 to FY2019).
  • Going back by year, Goodwill impairment charges was $138.15 million in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Arbutus Biopharma 755.33 Mn 382.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 29,000.00
Sep 30, 2019 22.47 Mn
API Access

Arbutus Biopharma Goodwill impairment charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-impairment-charges&ticker=ABUS&period=max&api_key=YOUR_API_KEY